Harrow HROW
NASDAQ HROW
$37.54 -0.31 (-0.82%)
As of: Sep 9, 2026 · 3:14 PM EDT

Harrow (HROW) EV to EBIT (2010 - 2026)

Harrow (HROW) posted EV to EBIT of 136.98 for Q2 2026, down 148.09% on a QoQ basis from 55.21 in Q1 2026, and down 246.33% year-over-year from 93.61 in Q2 2025.

Analysis

Harrow (HROW) EV to EBIT (2010 - 2026) Analysis & Trends

Harrow has reported EV to EBIT for 17 years, with the latest figure at 136.98 in Q2 2026.

  • On a quarterly basis, EV to EBIT fell 246.33% year-over-year to 136.98 in Q2 2026; TTM through Jun 2026 was 548.46, a 839.38% decrease from a year earlier, with the FY2025 full-year figure at 57.38, down 55.89% from the prior year.
  • EV to EBIT was 136.98 for Q2 2026 at Harrow, down from 55.21 in the prior quarter.
  • The five-year high for EV to EBIT was 1156.8 in Q3 2024, with the low at 2950.12 in Q3 2022.
  • Average EV to EBIT over 5 years is 21.93, with a median of 87.41 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: EV to EBIT tumbled 6118.21% in 2022, then soared 692.33% in 2023.
  • Over 5 years, EV to EBIT stood at 190.74 in 2022, then soared by 66.58% to 63.75 in 2023, then jumped by 239.56% to 88.96 in 2024, then climbed by 26.24% to 112.3 in 2025, then slumped by 221.97% to 136.98 in 2026.
  • The last three EV to EBIT figures came in at 136.98 (Q2 2026), 55.21 (Q1 2026), and 112.3 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn
2 AbbVie 442.18 Bn 435.61 Bn 12.70 Bn
3 Merck 366.59 Bn 359.45 Bn 12.21 Bn
4 Novartis Ag 266.49 Bn 258.80 Bn 11.24 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn
6 Sanofi 52.34 Bn 44.96 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn
10 Harrow 1.40 Bn 1.32 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -136.98
Mar 31, 2026 -55.21
Dec 31, 2025 112.30
Sep 30, 2025 115.93
Jun 30, 2025 93.61
Mar 31, 2025 -78.47
Dec 31, 2024 88.96
Sep 30, 2024 1,156.80
Jun 30, 2024 437.81
Mar 31, 2024 -56.55
Dec 31, 2023 -63.75
Sep 30, 2023 246.79
Jun 30, 2023 232.33
Mar 31, 2023 503.11
Dec 31, 2022 -190.74
Sep 30, 2022 -2,950.12
Jun 30, 2022 85.85
Mar 31, 2022 63.50
Dec 31, 2021 -103.37
Sep 30, 2021 -47.44